Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 72Neoplasms 64Prostatic Neoplasms 45Colorectal Neoplasms 42Lung Neoplasms 38Carcinoma, Non-Small-Cell Lung 26Pancreatic Neoplasms 21Neoplasm Metastasis 20Hematologic Neoplasms 20Head and Neck Neoplasms 20Urinary Bladder Neoplasms 15Ovarian Neoplasms 14Multiple Myeloma 11Motor Activity 11Leukemia, Myeloid, Acute 11Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Uterine Cervical Neoplasms 9Triple Negative Breast Neoplasms 9Glioblastoma 9Colonic Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 8Glioma 8Gastrointestinal Neoplasms 8Carcinoma, Renal Cell 8COVID-19 8Anxiety Disorders 8Anatomic Stage I Breast Cancer AJCC v8 8Rectal Neoplasms 7Melanoma 7

Interventions

Tobacco Use Cessation Devices 2Varenicline 1Tobacco Products 1Standard of Care 1Nivolumab 1Nicotine Replacement Therapy 1Nicotine Chewing Gum 1Methods 1Gain of Function Mutation 1Counseling 1Costs and Cost Analysis 1Community Resources 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Tobacco Smoking × Standard of Care × Clear all
NCT04691297 2025-12-19

Digitally Enhanced Smoking Cessation for High Risk Smokers

Dana-Farber Cancer Institute

Phase NA Active not recruiting
153 enrolled

Tobacco Smoking, Smoking, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡